Sunday, 17 July 2016

Best World Joint Venture with Prolife Biobank on Dental Stem CellBanking

My initial reactions on the JV were more negative. Personally think that management should focus on expanding their core business, especially ensuring execution of their business in China market. I also think that stem cell banking business seems to be a stretch from their current business.

However, the investment is only 2.5 mil. So it does not warrant any action at the moment. I am keeping faith with the management that they know what they are doing.

No comments:

Post a Comment